Home The Active Ingredient Matrix Terminalia arjuna (Arjunolic Acid)

Formulation Intelligence

Terminalia arjuna (Arjunolic Acid)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Terminalia arjuna (Arjunolic Acid).

Terminalia arjuna functions as a potent cardiotonic agent by modulating myocardial contractility and enhancing antioxidant defense mechanisms through the upregulation of endogenous enzymes like superoxide dismutase and catalase.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

73641

Molecular Weight

488.7 g/mol

XLogP3 (Lipophilicity)

5.8

IUPAC Name

(4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Coenzyme Q10 for synergistic mitochondrial ATP production and myocardial energy optimization
  • Withania somnifera for enhanced adaptogenic support and reduction of cortisol-induced cardiac stress

Biological Formulation Enhancers

  • Piperine for inhibition of P-glycoprotein and CYP3A4-mediated metabolism to increase triterpenoid bioavailability
  • Phosphatidylcholine for the formation of phytosomes to improve the lipophilic absorption of arjunolic acid

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Terminalia arjuna (Arjunolic Acid) across standard consumer modalities.

💊 Standard Capsules

The high hygroscopicity of concentrated arjuna extracts requires moisture-resistant HPMC capsules to prevent clumping and degradation of triterpenoid glycosides.

🍬 Gummy & Pectin Formats

The inherent astringency and high tannin content of arjuna bark extract pose significant challenges for flavor masking and can interfere with pectin gelation.

🔬 Thin-Film Oral Strips

The high therapeutic dose required for clinical efficacy exceeds the typical 50mg payload capacity of thin-film polymer matrices.

For Brand Founders

Formulate with Terminalia arjuna (Arjunolic Acid)

Ready to launch a product featuring Terminalia arjuna (Arjunolic Acid)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Terminalia arjuna (Arjunolic Acid) Bioavailability

Need absolute proof that your Terminalia arjuna (Arjunolic Acid) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Terminalia arjuna (Arjunolic Acid) Degradation Testing

Is your Terminalia arjuna (Arjunolic Acid) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation